- Home
- AARD vs KRMD Comparison
AARD vs KRMD Comparison
Compare AARD & KRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AARD
- KRMD
- Stock Information
- Founded
- AARD 2017
- KRMD 1980
- Country
- AARD United States
- KRMD United States
- Employees
- AARD N/A
- KRMD N/A
- Industry
- AARD Biotechnology: Pharmaceutical Preparations
- KRMD Medical/Dental Instruments
- Sector
- AARD Health Care
- KRMD Health Care
- Exchange
- AARD Nasdaq
- KRMD Nasdaq
- Market Cap
- AARD 231.9M
- KRMD 186.3M
- IPO Year
- AARD 2025
- KRMD N/A
- Fundamental
- Price
- AARD $9.91
- KRMD $4.37
- Analyst Decision
- AARD Strong Buy
- KRMD Strong Buy
- Analyst Count
- AARD 8
- KRMD 4
- Target Price
- AARD $30.63
- KRMD $4.63
- AVG Volume (30 Days)
- AARD 162.6K
- KRMD 101.9K
- Earning Date
- AARD 11-13-2025
- KRMD 11-12-2025
- Dividend Yield
- AARD N/A
- KRMD N/A
- EPS Growth
- AARD N/A
- KRMD N/A
- EPS
- AARD N/A
- KRMD N/A
- Revenue
- AARD N/A
- KRMD $39,070,637.00
- Revenue This Year
- AARD N/A
- KRMD $21.08
- Revenue Next Year
- AARD N/A
- KRMD $16.37
- P/E Ratio
- AARD N/A
- KRMD N/A
- Revenue Growth
- AARD N/A
- KRMD 22.12
- 52 Week Low
- AARD $4.88
- KRMD $1.86
- 52 Week High
- AARD $19.58
- KRMD $5.05
- Technical
- Relative Strength Index (RSI)
- AARD 39.27
- KRMD 60.55
- Support Level
- AARD $9.34
- KRMD $3.71
- Resistance Level
- AARD $11.51
- KRMD $4.49
- Average True Range (ATR)
- AARD 0.85
- KRMD 0.22
- MACD
- AARD -0.01
- KRMD 0.03
- Stochastic Oscillator
- AARD 20.39
- KRMD 78.21
About AARD Aardvark Therapeutics Inc.
Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.
About KRMD KORU Medical Systems Inc. (DE)
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).